Cypress Advisory Group’s Oscar Health OSCR Stock Holding History

Cypress Advisory Group’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-49,695	Closed	-$941K	–	74
2025 Q3	$941K	Buy	+49,695	New	+$819K	0.7%	47

Other funds holding OSCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cypress Advisory Group's OSCR Position: Q4 2025 in Review

Cypress Advisory Group sold out of Oscar Health (OSCR) in Q4 2025, closing a stake of 49,695 shares — an estimated $941K sold.

Cypress Advisory Group first reported a position in OSCR in Q3 2025 and held it in 1 quarter. The position peaked at $941K in Q3 2025. 343 funds tracked by Wall St. Rank hold OSCR as of Q4 2025.

Cypress Advisory Group reported no remaining Oscar Health position as of Q4 2025 after selling out during the quarter.
Cypress Advisory Group sold 49,695 Oscar Health shares in Q4 2025, an estimated $941K.
Cypress Advisory Group first reported a position in Oscar Health in Q3 2025 and held it in 1 quarter.
Cypress Advisory Group's Oscar Health position peaked at $941K in Q3 2025.
343 funds tracked by Wall St. Rank held Oscar Health as of Q4 2025.

Based on Cypress Advisory Group's 13F filing for Q4 2025, filed 20 Jan 2026.